[EN] BIO-ORTHOGONAL DRUG ACTIVATION<br/>[FR] ACTIVATION DE MÉDICAMENT BIO-ORTHOGONALE
申请人:TAGWORKS PHARMACEUTICALS B V
公开号:WO2014081301A1
公开(公告)日:2014-05-30
Disclosed is a kit for the administration and activation of a Prodrug. The kit comprises a Masking Moiety linked, directly or indirectly, to a Trigger moiety, which in turn is linked to a Drug, and an Activator for the Trigger moiety. The Trigger moiety comprises a dienophile and the Activator comprises a diene, whereby the dienophile is an eight-membered non- aromatic cyclic alkenylene group, preferably a cyclooctene group, and more preferably a trans-cyclooctene group. The Trigger and the Activator undergo a fast, bio-orthogonal reaction resulting in the release of the Masking Moiety, and activation of the drug.
揭示了一种用于给予和激活前药的工具包。该工具包包括一个掩蔽基团,直接或间接地连接到一个触发基团,该触发基团又连接到一种药物,以及一个用于触发基团的激活剂。触发基团包括一个二烯烃,激活剂包括一个二烯,其中二烯烃是一个八元非芳香环烯基团,优选为环辛烯基团,更优选为反式环辛烯基团。触发基团和激活剂经历一个快速的生物正交反应,导致掩蔽基团的释放和药物的激活。